These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Abraham WT, Young JB, León AR, Adler S, Bank AJ, Hall SA, Lieberman R, Liem LB, O'Connell JB, Schroeder JS, Wheelan KR, Multicenter InSync ICD II Study Group. Circulation; 2004 Nov 02; 110(18):2864-8. PubMed ID: 15505095 [Abstract] [Full Text] [Related]
6. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction). Linde C, Mealing S, Hawkins N, Eaton J, Brown B, Daubert JC, REVERSE study group. Eur Heart J; 2011 Jul 02; 32(13):1631-9. PubMed ID: 21112898 [Abstract] [Full Text] [Related]
14. Effect of cardiac resynchronization therapy in patients with moderate left ventricular systolic dysfunction and wide QRS complex: a prospective study. Fung JW, Zhang Q, Yip GW, Chan JY, Chan HC, Yu CM. J Cardiovasc Electrophysiol; 2006 Dec 02; 17(12):1288-92. PubMed ID: 16987381 [Abstract] [Full Text] [Related]
15. Cardiac resynchronization therapy in patients with a narrow QRS complex. Bleeker GB, Holman ER, Steendijk P, Boersma E, van der Wall EE, Schalij MJ, Bax JJ. J Am Coll Cardiol; 2006 Dec 05; 48(11):2243-50. PubMed ID: 17161254 [Abstract] [Full Text] [Related]
20. Biventricular vs. left univentricular pacing in heart failure: rationale, design, and endpoints of the B-LEFT HF study. Leclercq C, Ansalone G, Gadler F, Boriani G, Perez-Castellano N, Grubb N, Sack S, Boulogne E. Europace; 2006 Jan 05; 8(1):76-80. PubMed ID: 16627414 [Abstract] [Full Text] [Related] Page: [Next] [New Search]